The New Zelnorm-al: US FDA’s Do-Over On Cardiovascular Safety

Zelnorm’s revival is self-conscious effort to revisit a decision made in “Safety First” era a decade ago. Is dropping CV outcomes standard for diabetes drugs next?

Nostalgia Past remember Flashback impossible Relive reverse time Retrospective History old turn back Save memories of past and nostalgic memory find purpose of life warm vintage tone color

More from Drug Safety

More from Pink Sheet